The Company evaluated its indefinite-lived intangible assets for impairment and concluded there were no indicators of impairment as of June 30, 2026.

The assessment of goodwill by reporting unit is performed annually, in the fourth quarter, or more frequently if events or circumstances indicate the carrying value may no longer be recoverable and that an impairment loss may have occurred. The Company considered the current and expected future economic and market conditions and its impact on the Company’s reporting unit. Based on interim assessments, the Company did not identify any “triggering” events which would indicate an impairment of goodwill as of June 30, 2026.

The following table presents the composition of the Company’s intangible assets and goodwill (in thousands):


	Weighted-		As of June 30, 2026							As of December 31, 2025
	Average		Gross							Gross
	Amortization		Carrying		Accumulated			Net		Carrying		Accumulated			Net
	Period (in years)		Amount		Amortization			Amount		Amount		Amortization			Amount
Photrexa developed technology		4.7	$	7,801	$	(6,996	)	$	805	$	7,801	$	(3,322	)	$	4,479
Epioxa developed technology		6.0		111,700		(12,410	)		99,290		111,700		(3,103	)		108,597
License		4.0		5,190		(1,098	)		4,092		5,190		(435	)		4,755
In place leases		3.8		666		(477	)		189		666		(345	)		321
Mobius developed technology and customer relationships		9.0		17,800		(2,225	)		15,575		17,800		(1,236	)		16,564
Intangible assets subject to amortization				143,157		(23,206	)		119,951		143,157		(8,441	)		134,716

Acquired in-process research and development	Indefinite		$	7,200	$	-		$	7,200	$	7,200	$	-		$	7,200

Total			$	150,357	$	(23,206	)	$	127,151	$	150,357	$	(8,441	)	$	141,916

Goodwill	Indefinite		$	66,710	$	-		$	66,710	$	66,710	$	-		$	66,710

Actual amortization expense to be reported in future periods could differ from these estimates as a result of asset impairments, acquisitions, or other facts and circumstances.